Acremonium kiliense: reappraisal of its clinical significance

Ziauddin Khan1, Khaled Al-Obaid, Suhail Ahmad

  • 1Department of Microbiology, Faculty of Medicine, Kuwait University, Safat, Kuwait. zkhan@hsc.edu.kw

Insights

Acremonium kiliense peritonitis, a rare fungal infection, was diagnosed using advanced molecular techniques. This case highlights the growing clinical importance of Acremonium kiliense in peritoneal dialysis patients.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Peritonitis is a serious complication in patients undergoing peritoneal dialysis.
  • Fungal peritonitis is less common than bacterial peritonitis but can be challenging to treat.
  • Acremonium species are infrequently reported as causes of human infection.

Observation:

  • A case of peritonitis caused by Acremonium kiliense in a peritoneal dialysis patient is presented.
  • The diagnosis was confirmed through consistent isolation of the fungus from peritoneal dialysate.
  • Fungal identification involved both traditional morphological assessment and modern sequencing of internal transcribed spacer (ITS) regions of ribosomal DNA (rDNA).

Findings:

  • Morphological characteristics and ITS rDNA sequencing definitively identified the causative agent as Acremonium kiliense.
  • Repeated isolation from dialysate confirmed the persistent nature of the fungal infection.
  • The successful identification method provides a reliable approach for diagnosing rare fungal peritonitis.

Implications:

  • This case suggests Acremonium kiliense may be an underrecognized pathogen in peritoneal dialysis-associated peritonitis.
  • Enhanced diagnostic methods, including molecular techniques, are crucial for identifying unusual fungal causes of infection.
  • Further research is warranted to understand the clinical significance and optimal management of Acremonium kiliense infections.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...